The serum-and glucocorticoid-regulated kinase (Sgk1) is essential for hormonal regulation of epithelial sodium channel-mediated sodium transport and is involved in the transduction of growth factor-dependent cell survival and proliferation signals. Growing evidence now points to Sgk1 as a key element in the development and/or progression of human cancer. To gain insight into the mechanisms through which Sgk1 regulates cell proliferation, we adopted a proteomic approach to identify up-or downregulated proteins after Sgk1-specific RNA silencing. Among several proteins, the abundance of which was found to be up-or downregulated upon Sgk1 silencing, we focused our attention of RAN-binding protein 1 (RANBP1), a major effector of the GTPase RAN. We report that Sgk1-dependent regulation of RANBP1 has functional consequences on both mitotic microtubule activity and taxol sensitivity of cancer cells.
INTRODUCTION
The serum-and glucocorticoid-inducible kinase (Sgk1) was originally described as a key enzyme with serine/threonine specificity acting in the hormonal regulation of sodium absorption by the amiloride-sensitive epithelial sodium channel. The gene coding for Sgk1 is a serum and glucocorticoid-sensitive gene, later found to be similarly regulated by other hormones, osmotic cell shrinkage and other triggers of cell stress. [1] [2] [3] The kinase protein product is activated by oxidative stress, insulin or growth factors through PDK1-dependent mechanisms Kobayashi et al. 4, 5 The hydrophobic motif (HOURS-motif) mTOR kinase phosphorylates Sgk1 at S422; 6 PDK1 then binds phospho-S422 in the Sgk1 HOURS-motif to achieve subsequent phosphorylation at T256 and full activation of the kinase. 5 Initially, Sgk1 was demonstrated to participate in the regulation of the renal epithelial sodium channel. [7] [8] [9] Since then, a wide variety of channels, transporters and further functions of Sgk1 have been identified. Sgk1-sensitive functions include the inhibition of apoptosis. 3 Specifically, Sgk1 transmits insulin and IGF1-dependent survival signals. 10, 11 Sgk1 also contributes to IL2-dependent antiapoptotic signals in kidney cancer cells. 12 In addition, Sgk1 directly phosphorylates MDM2, which directs p53 to ubiquitylation and proteosomal degradation, thus affecting the half-life of p53 and, in turn, cell cycle, differentiation and survival. 13 Taken together these data indicate that Sgk1 is potentially implicated in human carcinogenesis, a role that is further supported by the involvement of Sgk1 in other pathways that include activation of K þ channels and Ca 2 þ channels, Na þ /H þ exchangers, amino-acid transporters and glucose transporters, upregulation of nuclear factors NFkB and b-catenin, as well as downregulation of the transcription factors Foxo3a/FKHRL1. 3 Indeed, Sgk1 deficiency in a knock-out mouse model has recently been demonstrated to confer resistance to chemical carcinogenesis induction of colonic tumors in vivo 14 and to counteract the appearance of intestinal tumors in adenomatous polyposis coli (APC) deficiency. 15 To gain more insight into pathways affected by Sgk1 activity in colon cancer cells, in this work we have adopted a proteomic approach to identify proteins that are either upregulated or downregulated in the human colon carcinoma cell line RKO, a well-studied model of human colon carcinoma, 16, 17 with and without specific silencing for Sgk1, by means of Sgk1-specific short hairpin (sh) RNAs.
Using two-dimensional electrophoresis (2DE) gel electrophoresis followed by Nanoscale liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) analysis we discovered that Sgk1 silencing is associated with significant modifications in the abundance of a distinct group of proteins. Among the best identified protein spots, RAN-binding protein 1 (RANBP1) showed significant downregulation in Sgk1-silenced cells. RANBP1 protein abundance is known to affect many steps of mitotic progression, including the dynamic activity of microtubules. 15, [18] [19] [20] [21] [22] RAN is a major regulator of mitosis 23, 24 and was recently identified as a potential therapeutic target in cancers expressing higher Ras/MEK/ERK and PI3K/Akt/mTORC1 activities. 25 Sgk1 itself has been suggested to have a role in microtubule organization by phosphorylating the protein product of the N-myc downstream regulated gene. 26 We therefore elected to focus on Sgk1-dependent regulation of RANBP1 abundance. We report that Sgk1 regulates RANBP1 at the gene transcription level and that this has functional consequences on microtubule stability and on the cell sensitivity to taxol. Sgk1 modulates transcription of the RANBP1-coding gene We first focused on the search for possible mechanisms of Sgk1-dependent regulation of RANBP1. Sgk1 was unable to phosphorylate GST-RANBP1 and no molecular interaction was demonstrated between Sgk1 and RANBP1 in standard proteinprotein interaction assays, 13, 28, 29 including co-immunoprecipitation and GST pull-down assays (data not shown). In direct support of this idea, adenovirus-driven Sgk1 overexpression yielded an increased abundance of RANBP1 protein in RKO cells (Figure 2a ), proving that fluctuations in Sgk1 expression can affect the levels of RanBP1.
RESULTS AND DISCUSSION
The reduced RANBP1 abundance in Sgk1-silenced cells suggests, therefore, that Sgk1 has roles in either RANBP1 protein stabilization or in upregulating transcription of the RANBP1 gene. Quantitative reverse transcriptase-PCR assays demonstrated that RANBP1 mRNA levels significantly decreased in Sgk1-silenced RKO cells (Figure 2b ), strongly suggesting a role of Sgk1 in regulation of RANBP1 gene transcription.
To elucidate these mechanisms, we transfected RKO cells with the murine wild-type RANBP1 promoter. The sequence and functional organization of the RANBP1 promoter are characterized in depth, and critical functional elements are identified, including a TATA-less initiator element (arrowed in Figure 2c ) as well as Sp1- were loaded on SDS-polyacrylamide gel electrophoresis for immunoblotting using Sgk1 antibody (rabbit polyclonal, Upstate, Lake Placid, NY, USA), RANBP1 antibody (goat polyclonal, Santa Cruz, Santa Cruz, CA, USA), and beta tubulin antibody (rabbit polyclonal).
and E2F-binding sites (see Figure 2c for details). The E2F-and Sp1-binding sites are highly conserved in the murine and human promoters. We assessed the sensitivity of the RANBP1 promoter, either in the wild-type form (pTS-A), or mutagenized in transcription factor-binding sites, to Sgk1 levels in chloramphenicol acetyl transferase (CAT) reporter assays. We found that adenovirally driven Sgk1 overexpression increased RANBP1 promoter activity (Figure 2d ). When RANBP1 mutant promoters were transfected in Sgk1-overexpressing cells, we found that a mutant version lacking the E2F-binding element (pmE construct) retained the ability to be upregulated by Sgk1, whereas mutational inactivation of the Sp1-binding element (pmS construct) reduced drastically the promoter responsiveness to Sgk1-dependent activation (Figure 2d ). These data indicate that Sgk1 upregulates RANPB1 transcription and that the Sp1 transcription factor has a role in Sgk1-dependent RANBP1 promoter activation.
Sgk1 phopshorylates Sp1 SP1 was traditionally thought of as a housekeeping factor. Growing evidence, however, indicates that phosphorylation, acetylation, sumoylation, ubiquitylation and glycosylation are among the post-translational modifications that can modulate the trans-activating potential and stability of Sp1. 34 Given the implication of Sp1 in Sgk1-dependent modulation of RANBP1 transcription, we wondered whether Sgk1 modifies Sp1 and hence its transactivation potential. In vitro phosphorylation assays showed indeed that active Sgk1 was able to phosphorylate GST-purified Sp1 (Figure 2e, lane 4) . Sgk1 also phosphorylates GST-delta 1 Sp1 (residues 1-110), containing the N-terminal transactivation domain (Figure 2e lower panel) , but is unable to phosphorylate a S59A delta 1Sp1 mutant (Figure 2f and Supplementary File 7 for an additional independent experiment).
These assays demonstrate that Sp1 is a genuine target of Sgk1 and that Sgk1 phosphorylates serine 59 in the transactivation domain of Sp1, a substrate shared with PKC-alpha and Erk1 kinases. 35 Downregulating Sgk1 abundance mimicks RANBP1 silencing in RKO cells and modulates the cell response to taxol RANBP1 protein abundance affects multiple aspects of mitosis, including the dynamic activity of the spindle microtubules. RANBP1 inactivation by either antibody microinjection 18 or by RNA interference 21, 22 induced microtubule hyper-stabilization, apoptosis during mitosis-reminiscent of the effects of the microtubule-stabilizing drug taxol-and increased cell death in response to taxol in several transformed cell lines. 36 Given that Sgk1 acts as a positive regulator of RANBP1 expression, downregulating Sgk1 levels should have similar functional consequences to those caused by direct RANBP1 silencing. If so, downregulation of Sgk1 should enhance the sensitivity of cells to Taxol.
In a first set of experiments, we examined the ability of taxol to arrest mitotic progression. This can be measured by assessing the fraction of RKO cells, either silenced or overexpressing Sgk1, that arrest in prometaphase after taxol treatment (representative examples of prometaphase arrest are shown n Figure 3a ). Taxol administration (10 nM) for 16 h yielded a significant increase in prometaphase-blocked cells in ShSgk1 compared with control Shscrl RKO cultures; furthermore, at identical taxol concentrations, adenovirally driven Sgk1 overexpression significantly decreased this fraction (percent variations are quantified in the graph in Figure 3a) ; thus, Sgk1 expression affects taxol-induced mitotic arrest in cancer cells in culture, most likely via modulation of RanBP1 expression, although the prosurvival function of Sgk1, when overexpressed, might also contribute to this effect. and Myc-Sgk1 were detected using goat polyclonal and rabbit polyclonal anti-Myc (both from Santa Cruz). Beta tubulin, detected by rabbit polyclonal, was used as a loading control. Adenovirus expressing wild-type Myc-tagged Sgk1 was prepared as described. 30 Briefly to make an E1-substituted virus, Psi5 adenovirus was used as a donor virus to supply the viral backbone. The Psi5 packaging site was flanked by directly repeated loxP sites. 293/CRE 8 cells were used to produce recombinant virus particles in the presence of the shuttle plasmid with a single loxP site containing the Myc-Sgk1 sequence, sublconed from the original pciNeoSgk1. 5 Cesium chloride gradient-purified viruses were used at 1:250 dilution in cell culture medium. Sgk1 expression was detectable 24 h after infection for at least 72 h. Cells infected with adenovirus driving Sgk1 expression are named AdSgk1-Rko cells, control cells infected with Psi5 adenovirus are named Psi5-Rko cells. (b) Quantitative PCR (q-PCR) quantification of RANBP1 mRNA levels in ShSgk1-and ShScrl-Rko cells. cDNA was synthesized from 1 mg total RNA using SuperScript III RNase HOURS-reverse transcriptase (Invitrogen, San Giuliano Milanese, Italy) and 2.5 mM random hexamers (Invitrogen). cDNA aliquots were amplified in an Applied Biosystems 7500 thermal cycler (Applied Biosystems, Branchburg, NJ, USA) using SYBR Green PCR master mix (Applied Biosystems) in the presence of RANBP1-specific primers (fw: 5 0 -AGA AAG CAG GAT CAG GCA AA-3 0 , rev: 5 0 -AGC TTT TCC GCC ACT TTT TC-3 0 ) for 40 cycles (95 1C 10 min 1 cycle; 95 1C 10 s, 55 1C 60 s). RANBP1 q-PCR products were normalized to the housekeeping Hypoxanthine phophoribosyl-transferase (HPRT) gene. Results, expressed as the mean ± s.e.m. of quadruplicates samples, were evaluated by t-test. (c) Map of the murine wild-type RANBP1 promoter (pTS-A) with relevant transcription factor-binding sites. Basal transcription requires a proximal promoter region encompassing the major transcription start sites (arrowed) and harboring a bona fide Sp1-binding site (Sp1.2), an initiator element termed Htf9 footprinted element and a target site for E2F-4/p107 factors. G1/S upregulation of RanBP1 transcription is controlled by upstream elements, including binding sites for E2F-1/pRb (E2F-b site) and Sp1 (Sp1.3 site) factors. The position of mutagenized sites is indicated: pmE, mutant promoter in the E2F-b element; pmS, mutant promoter in the Sp1.3 element (details in Di Fiore et al. 31 ). (d) CAT activity driven by pTS-A (wild-type), pmE (E2F-mutagenized) and pmS (Sp1-mutagenized) promoter constructs in AdSgk1 vs Psi5RKO cells. Twenty-four hours after infection AdSgk1-and AdSgk1-Rko cells were transfected with 10 mg of RANBP1 promoter reporter vectors and 1 mg of co-transfected beta-gal reporter for control. Twenty-four hours after transfection cells were lysed. The lysate was cleared by centrifugation and assayed for CAT activity as described, 32, 33 in the presence of 1 mCi of [14C]chloramphenicol (50 mCi/mmol; New England Nuclear Corp.) and 20 ml of 4 mM acetyl coenzyme A. After autoradiography, the spots corresponding to the separated acetylated chloramphenicol forms were cut out and counted. Counts in the acetylated chloramphenicol spots recovered from AdSgk1-Rko cell extracts are expressed relative to the counts recorded in the acetylated chloramphenicol spot recovered from Psi5-Rko cell extracts (taken as 100). Results, expressed as the mean ± s.e.m. of three independent experiments, were evaluated by t-test. (e) In vitro phosphorylation assays of GST, GST-purified Sp1 or GST-delta 1S59 Sp1 (kindly provided by Dr Kyoung Lim, Ajou University School of Medicine, Suwon, Korea) in the absence or presence of Sgk1 as indicated. The gel on the right shows the separation of bacterially produced GST-Sp1 and GST-delta1 Sp1 in pGEX3T3. Dialyzed GST, GST-SP1, GST-SP1-S59 delta1 were used as substrates in an in vitro kinase assay. Phosphorylation was detected by 32P incorporation into the GST fusion protein in the presence of [g-32P]ATP (0.02 mCi per sample). Samples were incubated in kinase buffer (200 mM MgCl2, 100 mM Tris-HCl pH 7.5, 2 mM DTT, 100 mM ATP) at room temperature for 30 min on a rotating wheel. The reaction was blocked by adding 50 ml SDS sample buffer. Samples were resolved by SDS-polyacrylamide gel electrophoresis, and phosphoproteins were detected by autoradiography. (f ) In vitro phosphorylation assays of GST-delta 1 S59 Sp1 and GST-delta 1 S59A Sp1. Phosphorylation was performed as described above. The GST-delta1 S59A mutant was produced by means of QuikChange Site-Directed Mutagenesis Kit following the instructions of the manufacturer.
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The ability of Sgk1 to modulate the extent of taxol-induced mitotic arrest is expected to also affect the apoptotic response to taxol. To address this question, Sgk1-defective and -proficient cultures were subjected to short-term (4 h) exposure to a higher taxol concentration (100 nM). Cells in early apoptotic stages were revealed by their binding to Annexin V in fluorescence-activated cell sorting analysis. This treatment induced low levels of apoptosis in ShScrl RKO control samples, whereas apoptosis significantly increased in ShSgk1 cell lines (Figure 3b ). These data are consistent with results previously obtained by direct RANBP1 downregulation. 36 The increase in cell death was reversed by transfection of shSgk1 cells with a vector encoding RFP-RanBP1. This strongly suggests that the effects of Sgk1 silencing on the cell sensitivity to taxol are mediated, at least in part, via RanBP1 downregulation (Figure 3b) . We also evaluated the effects of longterm (16 h) exposure to taxol (10 nM) on apoptosis, assessed by measuring the appearance of sub-G1 cells by propidium iodine staining (late apoptosis). Detailed cell cycle features of taxoltreated hScrl and ShSgk1 RKO cultures are shown in Supplementary File 8. Taxol treatment significantly increased the induction of sub-G1 cells both in ShScrl and ShSgk1 RKO cultures, though more effectively in Sgk1-silenced cultures (Figure 3c) . Interestingly, RANBP1 expression from a GFP-tagged expression construct in ShSgk1 cells almost completely prevented taxolinduced apoptosis (Figure 3c ), while having a negligible effect in ShScrl cultures that express native RANBP1 levels. These results are fully consistent with those obtained using Annexin V and confirm the importance of RANBP1 downregulation in sensitizing colon cancer cells to cell death induction by taxol.
RANBP1 is a major effector of the GTPase RAN: it cooperates with RANGAP1 (RAN GTPase-activating protein) in regulating GTP hydrolysis on RAN; in addition, it binds RANGTP and modulates its association with or dissociation from effectors of the family of nuclear transport receptors (for example, importin beta and exportin/CRM1). 37, 38 Through this dual activity, RANBP1 modulates RAN-dependent signals in all downstream-regulated processes, that is interphase nuclear import and export, mitotic spindle organization and nuclear reformation after mitosis. 23, 24, 39 Among RAN network members, RANBP1 has the unique property of being transcriptionally regulated during the cell cycle. RANBP1 transcriptional control is ensured via E2F-and Sp1-regulated promoter elements. 31 Disrupting cell cycle-regulated RANBP1 transcription displays the most significant consequences in mitosis: indeed, RANBP1 overexpression yields multipolar spindles with fragmented centrosomes, 19 whereas downregulation induces microtubule stabilization and impairs the spindle dynamic activity. 21, 22, 36 Loss of control of these mechanisms, associated with RANBP1-deregulated expression, ultimately affects the accuracy of chromosome segregation and can contribute to cancer development.
This work shows that Sgk1 regulates RANBP1 gene transcription in RKO colon carcinoma cells. Experiments with site-specific RANBP1 promoter mutants identify the SP1 site as a pivotal element in Sgk1-dependent RANBP1 transcriptional regulation. We concomitantly show that Sgk1 phosphorylates Sp1 in serine 59 in the N-terminal activation domain, reported to be essential for Sp1-dependent regulation of gene expression. Interestingly, it has recently been suggested that Sp transcription factors, particularly Sp1, act in concert with the PI3K-dependent pathway to regulate the alterations in cell metabolism caused by malignant transformation. 40 The results presented here indicate that Sgk1 silencing enhances taxol-induced apoptosis compared with wild-type cells, similar to direct RANBP1 inactivation; moreover, an ectopically expressed RANBP1-encoding transgene counteracted the effects of taxol in Sgk1 downregulated cells; thus, at least these effects of Sgk1 are largely mediated by RANBP1 in RKO cells. Although reduced Sp1ser59 phosphorylation will likely affect a broad set of genes, hence directly or indirectly affecting the expression of several proteins (as also indicated by our proteomics profiling of Sgk1-downregulated RKO cells), the present results identify a regulatory axis that includes Sgk1, Sp1 and RANBP1, which affects the response of colon cancer cells to taxol. Mitotic regulatory genes modulate the response of cancer cells to microtubuletargeting drugs, particularly taxanes, which are widely employed in cancer chemotherapy. 41 An important implication of the present findings is that cancers overexpressing SGK1 might be more resistant to taxane-dependent induction of cell death due to their elevated RANBP1 expression level. Sgk1 emerges, therefore, as a crucial factor in carcinogenesis and drug resistance. As Sgk1 is itself regulated at both the transcriptional and post-translational level, 2 the functional relation between Sgk1 and RANBP1 may also contribute to the link between metabolism, chronic stress 42 and cancer. . Cells were grown on coverslips in 6-well culture dishes in Dulbecco's modified eagle medium (Invitrogen). When roughly 50% confluent, they were serum-starved overnight, then supplemented with 10% fetal bovine serum and later treated with 10 nMol taxol for 16 h. Cells were finally fixed in 3.7% formaldehyde for 20 min, permeabilized in 0.5% Triton X-100 for 1 min and washed with phosphate-buffered saline (PBS) (pH 7.4). Samples were incubated with pericentrin rabbit antibody (Babco, 1:500 dilution) and beta tubulin mouse antibody (Life Span Biosciences, 1:500 dilution) for 2 h at room temperature in PBS (pH 7.4) containing bovine serum albumin (1 mg/ml) and Tween-20 (0.2%), then washed in PBS and incubated with FITC-conjugated goat anti-rabbit Ig to detect pericentrin, TRITC-conjugated goat anti-mouse Ig to detect beta tubulin and 4' ,6-diamidino-2-phenylindole (0.05% mg ml 
